bioAffinity Technologies Welcomes New Board Members
November 29, 2017 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
bioAffinity Technologies Adds Four Scientists to Research & Commercialization Team
June 28, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, June 28, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early stage cancer diagnostics and precision cancer therapeutics, today announced four...
bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
bioAffinity Awarded New Patent; Company’s Patent Portfolio Continues to Expand
August 24, 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Aug. 24, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced that it has been awarded a U.S. Patent protecting a proprietary kit that contains the...
bioAffinity Technologies Forms Subsidiary to Focus on Targeted Cancer Drug Delivery
June 23, 2016 08:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, June 23, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s...
bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference
April 12, 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...
Inform Genomics Presents Biologic Validity for OnPART Predictive Networks Identifying Potential Genomic Targets for Drug Discovery
June 03, 2013 08:00 ET
|
Inform Genomics
Boston, MA, June 3, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...